inotuzumab,brexucabtagene autoleucel,blinatumomab
ucb pharmaceuticals,amgen,gilead,pfizer,astellas
['zuma-3', 'zuma3', 'brexu-cel', 'blinatumomab', 'inotuzumab', 'leusm']
congress | #ash22 | poster bijal d. shah presented updated outcomes from the historical control study scholar-3 contextualizing zuma-3 results of kte-x19 in adult pts with r/r b-all. results showed considerable benefits of kte-x19 over soc therapies #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm